These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 33883227)

  • 1. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
    Hamed ZO; Awni AA; Abdulamir AS
    Arch Microbiol; 2023 Mar; 205(4):104. PubMed ID: 36869962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel
    Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
    mSphere; 2017; 2(2):. PubMed ID: 28357414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining of Gram-Negative Surface-Active Enzybiotic Candidates by Sequence-Based Calculation of Physicochemical Properties.
    Vázquez R; Blanco-Gañán S; Ruiz S; García P
    Front Microbiol; 2021; 12():660403. PubMed ID: 34113327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage-derived endolysins to target gram-negative bacteria.
    Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY
    Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage endolysins are adapted to specific hosts and are evolutionarily dynamic.
    Oechslin F; Zhu X; Dion MB; Shi R; Moineau S
    PLoS Biol; 2022 Aug; 20(8):e3001740. PubMed ID: 35913996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriophage lysins: progress and perspective--a review].
    Wang Y; Lu C
    Wei Sheng Wu Xue Bao; 2009 Oct; 49(10):1277-81. PubMed ID: 20069871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage endolysins as a novel class of antibacterial agents.
    Borysowski J; Weber-Dabrowska B; Górski A
    Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages that infect Gram-negative bacteria as source of signal-arrest-release motif lysins.
    Gontijo MTP; Vidigal PMP; Lopez MES; Brocchi M
    Res Microbiol; 2021 Mar; 172(2):103794. PubMed ID: 33347948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic screen to identify bacteriophage lysins.
    Schuch R; Fischetti VA; Nelson DC
    Methods Mol Biol; 2009; 502():307-19. PubMed ID: 19082564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage lytic enzymes: novel anti-infectives.
    Fischetti VA
    Trends Microbiol; 2005 Oct; 13(10):491-6. PubMed ID: 16125935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysins as a powerful alternative to combat Bacillus anthracis.
    Nakonieczna A; Abramowicz K; Kwiatek M; Kowalczyk E
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):366. PubMed ID: 38850320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain.
    Vázquez R; Seoane-Blanco M; Rivero-Buceta V; Ruiz S; van Raaij MJ; García P
    Acta Crystallogr D Struct Biol; 2022 Apr; 78(Pt 4):435-454. PubMed ID: 35362467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced engineering of third-generation lysins and formulation strategies for clinical applications.
    De Maesschalck V; Gutiérrez D; Paeshuyse J; Lavigne R; Briers Y
    Crit Rev Microbiol; 2020 Sep; 46(5):548-564. PubMed ID: 32886565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Occurrence and Multimerization of Two-Polypeptide Phage Endolysins Encoded in Single Genes.
    Pinto D; Gonçalo R; Louro M; Silva MS; Hernandez G; Cordeiro TN; Cordeiro C; São-José C
    Microbiol Spectr; 2022 Aug; 10(4):e0103722. PubMed ID: 35876588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.
    Low LY; Yang C; Perego M; Osterman A; Liddington R
    J Biol Chem; 2011 Sep; 286(39):34391-403. PubMed ID: 21816821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Phage Lysins as Novel Therapeutics: A Historical Perspective.
    Fischetti VA
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29875339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage lysins for intestinal microbiome modulation: current challenges and enabling techniques.
    Pottie I; Vázquez Fernández R; Van de Wiele T; Briers Y
    Gut Microbes; 2024; 16(1):2387144. PubMed ID: 39106212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci.
    Binte Muhammad Jai HS; Dam LC; Tay LS; Koh JJW; Loo HL; Kline KA; Goh BC
    Front Microbiol; 2020; 11():574739. PubMed ID: 33324362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.